Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Titel:
Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Auteur:
Petit, P.-F. Daoudlarian, D. Latifyan, S. Bouchaab, H. Mederos, N. Doms, J. Abdelhamid, K. Ferahta, N. Mencarelli, L. Joo, V. Bartolini, R. Stravodimou, A. Shabafrouz, K. Pantaleo, G. Peters, S. Obeid, M.